This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Procell Therapeutics Inc.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Jin Kyung Song: Innovator in Macromolecule Transduction Domains
Introduction
Jin Kyung Song is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of macromolecule transduction domains. With a total of 2 patents, his work focuses on enhancing the delivery of biologically active molecules across cell membranes.
Latest Patents
One of Jin Kyung Song's latest patents is titled "Macromolecule transduction domains and methods for identification and uses thereof." This invention discloses novel macromolecule transduction domain (MTD) peptides that facilitate the traverse of biologically active molecules across cell membranes. The patent also includes polynucleotides encoding the MTD peptides, methods for identifying these peptides, and techniques for genetically engineering biologically active molecules to enhance their cell permeability using MTD peptides.
Career Highlights
Jin Kyung Song is currently associated with Procell Therapeutics Inc., where he continues to innovate in the field of biotechnology. His work is pivotal in advancing methods that improve the delivery of therapeutic agents, which can have significant implications for medical treatments.
Collaborations
Some of his notable coworkers include Thi Lan Phuong Do and Thi Thuy Nga Do, who contribute to the collaborative efforts at Procell Therapeutics Inc. Their teamwork enhances the research and development processes within the company.
Conclusion
Jin Kyung Song's contributions to the field of biotechnology through his innovative patents are noteworthy. His work on macromolecule transduction domains is paving the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile